Авторы

  • Ташматов С.А., Рузиназаров Б.А.
  • Назаров Б.С.

Ключевые слова:

интракраниальная герминома, супраселлярная область, дети, SALL4, OCT3/4, PLAP, CD117, иммуногистохимия, стереотаксическая биопсия.

Библиографические ссылки

1. Louis D.N., Perry A., Wesseling P., et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23 (8):1231-1251.

2. Ostrom Q.T., Cioffi G., Waite K., et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018. Neuro Oncol. 2021;23 (Suppl 2):iii1-iii105.

3. Matsutani M., Sano K., Takakura K., et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg. 1997;86(3):446-455.

4. Echevarría M.E., Fangusaro J., Goldman S. Pediatric central nervous system germ cell tumors: a review. Oncologist. 2008;13(6):690-699.

5. Murray M.J., Bartels U., Nishikawa R., et al. Consensus on the management of intracranial germ-cell tumours. Lancet Oncol. 2015;16(11):e470-e477.

6. Calaminus G., Frappaz D., Kortmann R.D., et al. Outcome of patients with intracranial non-germinomatous germ cell tumors–lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol. 2017;19(12): 1661-1672.

7. Phi J.H., Kim S.K., Wang K.C. Intracranial germ cell tumor. J Korean Neurosurg Soc. 2015;57(5): 368-372.

8. Zygourakis C.C., DeBonis S.S., Lopes M.B. Suprasellar germ cell tumors in children. J Neurosurg Pediatr. 2020;25(5):528-537.

9. Hattab E.M., Tu P.H., Wilson J.D., Cheng L. OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. Am J Surg Pathol. 2005;29(3):368-371.

10. Alassiri A.H., Ali S., Murgoci A.N., et al. Immunohistochemical evaluation of CD117 and PLAP in intracranial germ cell tumors. Am J Surg Pathol. 2006;30(11):1455-1460.

11. Calaminus G., Kortmann R.D., Worch J., et al. SIOP CNS GCT 96: final report of treatment of intracranial germinoma. Neuro Oncol. 2013;15(6):745-754.

12. McCarthy B.J., Shibui S., Kayama T., et al. Primary CNS germ cell tumors in Japan and the United States: an analysis of 4,803 cases. Neuro Oncol. 2012;14(9):1198-1206.

13. Santagata S., Ligon K.L., Hornick J.L. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol. 2007;31(6):836-845.

14. Frappaz D., Pedone C., Bonneville M., et al. Management of intracranial germ cell tumors. Curr Oncol Rep. 2022;24(9):1131-1141.

15. Louis D.N., Ohgaki H., Wiestler O.D., et al. WHO Classification of Tumours of the Central Nervous System. Revised 4th ed. Lyon: IARC; 2016.

16. Reddy A.T., Packer R.J. Pediatric central nervous system germ cell tumors. J Neurooncol. 2020;150(1):79-89.

17. Mei K., Liu A., Allan R.W., et al. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Mod Pathol. 2009;22(12):1628-1636.

18. Russo A., Cappabianca P., Cavallo L.M. Endoscopic endonasal approach for suprasellar germinomas: a systematic review. World Neurosurg. 2023; 178:108-118.

19. Cao D., Humphrey P.A., Allan R.W. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer. 2009;115 (12):2640-2651.

20. Yoo C.H., Park H.G., Kim D.S., et al. Clinical outcomes of intracranial germinoma: a retrospective analysis of 76 cases. Childs Nerv Syst. 2024;40(1): 135-143.